This episode discusses the growing threat of sepsis, a life-threatening condition caused by the body's overwhelming response to an infection. It explores the connection between the rise in sepsis cases and the increasing problem of antibiotic resistance, highlighting the importance of effective diagnostic tools and antibiotic stewardship programs in combating this public health challenge.
Disclaimers:
This educational podcast activity is brought to you by QuidelOrtho Corporation., and is not certified for continuing medical education. QuidelOrtho Corporation sponsors the program, and the speaker must present information following applicable FDA requirements.
High-sensitivity troponin testing is not available in all regions. Please reach out to your QuidelOrtho representative for more information, or visit our website at quidelortho.com.
Cordell test = A cardiac stress test to evaluate the performance and function of the heart during physical activity.
About our Speaker:
About our Speaker:
Doctor Mike Broyles
Doctor of Pharmacy and Director of Medical Affairs for Biomarkers
Thermo Fisher Scientific
With more than 30 years of experience as a hospital pharmacy and laboratory director, Dr. Broyles is a leading expert on sepsis and the clinical use of drugs with
With more than 30 years of experience as a hospital pharmacy and laboratory director, Dr. Broyles is a leading expert on sepsis and the clinical use of drugs with a focus on antimicrobial stewardship. Prior to joining Thermo Fisher Scientific, Dr. Broyles was a consultant for over 25 years working with a large independent hospital network as pharmacy advisor chairman focused on developing and implementing hospital-wide clinical initiatives. Dr. Broyles has worked passionately throughout his career to define effective protocols and decision support processes in patient management and the use of diagnostic technology to help clinicians improve outcomes through better clinical care.
In this episode, you'll learn:
- The pathophysiology of sepsis, including how patients typically contract the condition and the presenting signs and symptoms.
- The factors contributing to the rise in sepsis cases and the consequences of antibiotic resistance.
- The diagnostic utility of the biomarker procalcitonin (PCT) in identifying patients at risk of sepsis, guiding antibiotic therapy, and supporting effective antibiotic stewardship programs.